By Sofia MoutinhoMay. 20, 2021 , 11:05 AM They are no bigger than sesame seeds, and they pulse with a hypnotic rhythm
By Sofia MoutinhoMay. 20, 2021 , 11:05 AM They are no bigger than sesame seeds, and they pulse with a hypnotic rhythm
Boston, MA, May 21, 2021 (GLOBE NEWSWIRE) -- Mass General Brigham today announced its selections for the sixth annual Disruptive Dozen, 12 emerging gene and cell therapy (GCT) technologies with the greatest potential to impact health care in the next few years. The technologies were featured as part of the World Medical Innovation Forum held virtually from Boston to examine GCTs potential to impact patient care including a range of diseases and health system opportunities
The Crown Prince of Abu Dhabi thanked scientists and medics during a tour of the city's stem cell centre on Thursday. Sheikh Mohamed bin Zayed, Deputy Supreme Commander of the Armed Forces, visited Abu Dhabi Stem Cell Centre, where researchers work to improve treatment for people with rare diseases
The global microcarrier market is anticipated to observe remarkable growth over the forecast period, owing to the rising number of cancer patients across the globe. By type, the equipment sub-segment is estimated to witness strong growth by 2027. Regionally, the North America region is anticipated to dominate the overall industry in the projected timeframe
Stem cell laws and policy in the United States have had a complicated legal and political history.
2 March, 2021 Can Stem Cell Research Save Endangered Species? Many species are facing eradication as the Earth undergoes its sixth mass extinction. Human innovation and changes to behavior, however, can slow down this annihilation of species through conscious environmental preservation, and surprisingly, stem cell research
Tzar Labs, a molecular diagnostic company, and Mumbai-based Epigeneres Biotechnology, have claimed a breakthrough with their RNA-marker based technology for early detection of cancer rooted in stem cell biology. The blood tests, which can help determine whether cancer is absent, imminent, or present and also detect the different stages of the disease; will be launched by the end of this year. Ashish Tripathi, founder and CEO of Tzar Labs, said that they are awaiting the regulatory approvals, and are building the first laboratory in Mumbai now.
NEW YORK, May 17, 2021 /PRNewswire/ --EB Research Partnership, the largest global nonprofit funding research to discover treatments and cures for Epidermolysis Bullosa (EB), today announces a $150,000 donation from Elongate, a cryptocurrency token focused on charitable giving, as the inaugural gift for the nonprofit's #CryptoForCures Fund, establishing Elongate as the Founding Member.
Increased incidence of genetic disorders and chronic diseases is projected to drive demand for regenerative medicine during the forecast period. The globalregenerative medicine marketis forecasted to reach a market size of USD 23.57 Billion by 2027, and register a significantly rapid revenue growth rate, according to a new report by Reports and Data
Cancer Stem Cell Therapy market research report provides detailed information on the following aspects: industry size, share, growth, segmentation, manufacturers and progress, main trends, market drivers, challenges, standardization, deployment models, opportunities, strategies, future roadmaps, and Annual forecast till 2026, etc. The report conducted a professional and in-depth analysis of the current situation of the Cancer Stem Cell Therapy market, including major players such as manufacturers, suppliers, distributors, traders, customers, and investors. The report also helps you understand the dynamic structure of the Cancer Stem Cell Therapy market by identifying and analyzing market segments.
Recent Comments